335 related articles for article (PubMed ID: 24595118)
1. Prostate cancer in Asian men.
Ito K
Nat Rev Urol; 2014 Apr; 11(4):197-212. PubMed ID: 24595118
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.
Kitagawa Y; Namiki M
Asian J Androl; 2015; 17(3):475-80. PubMed ID: 25578935
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer: an emerging threat to the health of aging men in Asia.
Zhang L; Yang BX; Zhang HT; Wang JG; Wang HL; Zhao XJ
Asian J Androl; 2011 Jul; 13(4):574-8. PubMed ID: 21552284
[TBL] [Abstract][Full Text] [Related]
4. East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians.
Kimura T
Chin J Cancer; 2012 Sep; 31(9):421-9. PubMed ID: 22085526
[TBL] [Abstract][Full Text] [Related]
5. Prostate Cancer Working Group report.
Namiki M; Akaza H; Lee SE; Song JM; Umbas R; Zhou L; Lee BC; Cheng C; Chung MK; Fukagai T; Hinotsu S; Horie S
Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i70-75. PubMed ID: 20870924
[TBL] [Abstract][Full Text] [Related]
6. Changing trends of prostate cancer in Asia.
Pu YS; Chiang HS; Lin CC; Huang CY; Huang KH; Chen J
Aging Male; 2004 Jun; 7(2):120-32. PubMed ID: 15672937
[TBL] [Abstract][Full Text] [Related]
7. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.
Carlsson S; Assel M; Sjoberg D; Ulmert D; Hugosson J; Lilja H; Vickers A
BMJ; 2014 Mar; 348():g2296. PubMed ID: 24682399
[TBL] [Abstract][Full Text] [Related]
8. Impact of PSA levels on second-round screening for the development of prostate cancer in men with low baseline PSA levels (≤2.0 mg/ml).
Kitagawa Y; Sawada K; Urata S; Izumi K; Ueno S; Kadono Y; Konaka H; Mizokami A; Namiki M
Anticancer Res; 2014 Nov; 34(11):6739-46. PubMed ID: 25368284
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of prostate cancer in Asian countries.
Kimura T; Egawa S
Int J Urol; 2018 Jun; 25(6):524-531. PubMed ID: 29740894
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
[TBL] [Abstract][Full Text] [Related]
11. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
Gandaglia G; Albers P; Abrahamsson PA; Briganti A; Catto JWF; Chapple CR; Montorsi F; Mottet N; Roobol MJ; Sønksen J; Wirth M; van Poppel H
Eur Urol; 2019 Aug; 76(2):142-150. PubMed ID: 31092338
[TBL] [Abstract][Full Text] [Related]
12. Updated results from the European Randomized Study of Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: are Asian countries encouraged to promote PSA screening?
Sugimoto M; Kakehi Y
Asian J Androl; 2012 Jul; 14(4):522-4. PubMed ID: 22751444
[No Abstract] [Full Text] [Related]
13. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
14. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
15. Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort.
Larsen SB; Brasso K; Iversen P; Christensen J; Christiansen M; Carlsson S; Lilja H; Friis S; Tjønneland A; Dalton SO
Eur J Cancer; 2013 Sep; 49(14):3041-8. PubMed ID: 23684783
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer risk prediction models in Eastern Asian populations: current status, racial difference, and future directions.
He BM; Chen R; Sun TQ; Yang Y; Zhang CL; Ren SC; Gao X; Sun YH
Asian J Androl; 2020; 22(2):158-161. PubMed ID: 31187780
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.
Butler SS; Muralidhar V; Zhao SG; Sanford NN; Franco I; Fullerton ZH; Chavez J; D'Amico AV; Feng FY; Rebbeck TR; Nguyen PL; Mahal BA
Cancer; 2020 Feb; 126(4):717-724. PubMed ID: 31794057
[TBL] [Abstract][Full Text] [Related]
18. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study.
Hjertholm P; Fenger-Grøn M; Vestergaard M; Christensen MB; Borre M; Møller H; Vedsted P
Int J Cancer; 2015 Jan; 136(2):435-42. PubMed ID: 24905402
[TBL] [Abstract][Full Text] [Related]
19. The 5th Conference on Asian Trends in Prostate Cancer Hormone Therapy.
Akaza H; Moore MA; Chang SJ; Cheng C; Choi HY; Esuvaranathan K; Hinotsu S; Hong SJ; Kim CS; Kim WJ; Murai M; Naito S; Soebadi D; Song JM; Umbas R; Usami M; Xia S; Yang CR
Asian Pac J Cancer Prev; 2007; 8(1):3-12. PubMed ID: 17477764
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen screening: pro.
Loeb S; Catalona WJ
Curr Opin Urol; 2010 May; 20(3):185-8. PubMed ID: 20224413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
